Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Monoclonal Antibody”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07610772
What this trial is testing

Safety and Antiviral Activity of a Monoclonal Hepatitis B Antibody: a Phase 1b, Open-label Trial in Individuals With Chronic Hepatitis D Infection

Who this might be right for
Hepatitis D, ChronicHepatitis B Chronic Infection
Aarhus University Hospital 15
Testing effectiveness (Phase 2)UnknownNCT04096911
What this trial is testing

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsCervical CancerCervical Neoplasms+1 more
Buhai Wang 20
Not applicableLooking for participantsNCT06659029
What this trial is testing

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users

Who this might be right for
Systemic Lupus Erythematosus
AstraZeneca 442
Early research (Phase 1)Study completedNCT02788175
What this trial is testing

Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 26
Post-approval studies (Phase 4)Study completedNCT01223612
What this trial is testing

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Who this might be right for
Diabetic Retinopathy
Moorfields Eye Hospital NHS Foundation Trust 37
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Early research (Phase 1)Active Not RecruitingNCT06824701
What this trial is testing

Tazemetostat in Combination With Zanubrutinib and Anti-CD20 Monoclonal Antibody in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
University of Utah 24
Not applicableUnknownNCT05201729
What this trial is testing

Influence Factors of PD-1 Therapeutic Efficacy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma, PDAC
Ruijin Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT06094881
What this trial is testing

A Prospective, One-arm and Open Clinical Study of Obinutuzumab in the Treatment of Pediatric Primary Immune Thrombocytopenia (ITP)

Who this might be right for
Immune ThrombocytopeniaTreatment
Institute of Hematology & Blood Diseases Hospital, China 60
Testing effectiveness (Phase 2)Ended earlyNCT03910439
What this trial is testing

Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma

Who this might be right for
Myeloma, MultipleMyeloma-Multiple
National Cancer Institute (NCI) 4
Early research (Phase 1)Study completedNCT00793975
What this trial is testing

Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy

Who this might be right for
Advanced Solid Tumors
Eli Lilly and Company 37
Post-approval studies (Phase 4)Study completedNCT06806657
What this trial is testing

Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to Garadacimab

Who this might be right for
Hereditary Angioedema
CSL Behring 18
Testing effectiveness (Phase 2)Study completedNCT01240720
What this trial is testing

A Dose Finding and Efficacy Study of the Tumour Targeting Human 131I-F16SIP Monoclonal Antibody in Patients With Cancer

Who this might be right for
Cancer
Philogen S.p.A. 65
Testing effectiveness (Phase 2)Study completedNCT00895180
What this trial is testing

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Glioblastoma Multiforme
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 80
Not applicableLooking for participantsNCT05264259
What this trial is testing

New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies

Who this might be right for
BK Virus Infection
University Hospital, Strasbourg, France 100
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT00020410
What this trial is testing

Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT04506320
What this trial is testing

Novel Drugs After Allo-HSCT in Patients With Multiple Myeloma

Who this might be right for
Multiple MyelomaStem Cell Transplant
Gruppo Italiano Trapianto di Midollo Osseo 202
Large-scale testing (Phase 3)Study completedNCT00003280
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Follicular or Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Swiss Cancer Institute 240
Large-scale testing (Phase 3)Ended earlyNCT04644185
What this trial is testing

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Who this might be right for
Covid19
Sinocelltech Ltd. 102
Next Page